Høyer-Hansen Group

Key Publications

Pass, J., Jögi, A., Lund,I.K., Rønø, B., Rasch,M.G., Gårdsvoll,H., Lund, L.R., Ploug, M., Rømer, J., Danø, K. and Høyer-Hansen, G.:
Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: Inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
Thromb.Haem. 2007; 97:1013-22.

Piironen, T., Haese, A., Huland, H., Steuber, T., Christensen, I.J., Brünner, N., Danø, K., Høyer-Hansen, G. and Lilja, H.:
Enhanced discrimination of benign from malignant prostatic disease by novel selective measurements of cleaved forms of urokinase receptor in serum.
Clin.Chem. 2006. 52: 838-844.

Almasi, C.E., Høyer-Hansen, G., Christensen, I.J., Danø, K. and Pappot H.:
Prognostic impact of liberated domain I of the urokinase plasminogen activator receptor in squamous cell lung cancer tissue.
Lung Cancer, 2005; 48:349-355.

Piironen, T., Laursen, B., Pass, J., List, K., Gårdsvoll, H., Ploug ,M., Danø, K. and Høyer-Hansen, G.:
Specific immunoassays for the detection of intact and cleaved forms of the urokinase receptor.
Clin. Chem., 2004;50:2059-68.

Høyer-Hansen, G., Pessara, U., Holm,A., Pass, J., Weidle, U., Danø, K. and Behrendt, N.:
Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.
Biochem.J. 2001, 358:673-679.